Malcolm L. H. Green

Bio: Malcolm L. H. Green is an academic researcher from University of Oxford. The author has contributed to research in topics: Carbon nanotube & Cyclopentadienyl complex. The author has an hindex of 82, co-authored 800 publications receiving 31121 citations. Previous affiliations of Malcolm L. H. Green include Gas Technology Institute & University of Illinois at Urbana–Champaign.

Synthesis and electrochemistry of crown ether dithiolene complexes

Abstract: The syntheses of copper and bis(η-cyclopentadienyl)molybdenum complexes of a dithiolene ligand incorporating a trioxadithia-15-crown-5-unit [1,4,7-trioxa-10,13-dithiacyclopentadec-11-ene-11,12-dithiolate(2–)] are described. The electrochemistry of these complexes was investigated by cyclic voltammetry in acetonitrile. Upon addition of an excess of alkali-metal cations large shifts of the redox potentials of the compounds were observed.

Improved processes for the conversion of methane to synthesis gas

Abstract: A method of converting a reactant gas mixture of CO2, O2 and CH4 comprises contacting the reactant gas at 750 - 850 °C with a solid catalyst, which is a d-block transition metal or oxide such as a group VIII metal on a metal oxide support such as alumina, and which selectively converts the reactant gas into a product gas mixture comprising H2 and CO.

Syntheses of the Uranium Complexes [U{N(SiMe(3))(2)}(2){N(SiMe(3))(SiMe(2)CH(2)B(C(6)F(5))(3))}] and [U{C(Ph)(NSiMe(3))(2)}(2){m(3)-BH(4)}(2)]. Determination of Hydrogen Positions by Single-Crystal X-ray and Neutron Diffraction.

Abstract: The complex [U{N(SiMe(3))(2)}(2){N(SiMe(3))(SiMe(2)CH(2)B(C(6)F(5))(3))}] (1) is formed in the reaction between the hydride complex [U{N(SiMe(3))(2)}(3)(H)] and B(C(6)F(5))(3), and H(2) is evolved. The X-ray [C(36)H(53)BF(15)N(3)Si(6)U.3.5C(6)D(6), triclinic, space group Po, Z = 2, 90 K, a = 14.065(1) A, b = 14.496(1) A, c = 18.759(1) A, alpha = 82.898(1) degrees, beta = 74.415(1) degrees, gamma = 62.919(1) degrees ] and neutron structure [C(36)H(53)BF(15)N(3)Si(6)U.3.5C(6)D(6), triclinic, space group Po, Z = 2, 20 K, a = 13.993(1) A, b = 14.484(1) A, c = 18.720(1) A, alpha = 82.810(1) degrees, beta = 74.200(1) degrees, gamma = 63.054(1)E] of compound 1, which crystallizes with 3.5 molecules of C(6)D(6) per asymmetric unit, show the electron deficiency of the uranium atom to be effectively compensated by the formation of multicenter bonds between U and three Si-CH(2) units of the amido ligands. The reaction of the uranium complex [U{C(Ph)(NSiMe(3))(2)}(2)(Cl)(2)] with [Na(BH(4))] gives the complex [U{C(Ph)(NSiMe(3))(2)}(2){m(3)-BH(4)}(2)] (2). The X-ray structure of 2 [C(26)H(54)B(2)N(4)Si(4)U, monoclinic, space group C2/c, Z = 4, 90 K, a = 21.613(1) A, b = 9.233(1) A, c = 18.132(1) A, beta = 98.804(1) degrees ] proves unequivocally the m(3) coordination of the BH(4) moieties. In both single-crystal X-ray structure determinations, all hydrogen and deuterium atoms could be located and isotropically refined, including those which are directly coordinated to the uranium. The reliability of the refined hydrogen and deuterium positions for compound 1 is confirmed by comparison of the X-ray and neutron structure determinations. The ability to locate the hydrogen and deuterium positions in these uranium compounds by single-crystal X-ray diffraction is due to good crystal quality, the measurement of data at low temperature, and the use of image plate technology for data collection.

Respiratory muscle weakness in the Lambert-Eaton myasthenic syndrome.

Abstract: Respiratory muscle function was assessed in six patients with the Lambert-Eaton myasthenic syndrome. Five had histologically proved small cell carcinoma of the lung; the sixth later developed metastases from an unknown primary site. Two patients had ventilatory failure, one without respiratory symptoms; another, who had emphysema, had dyspnoea and orthopnoea. The remaining three patients had no respiratory symptoms. Four patients had limb muscle weakness as judged by the maximal voluntary contraction of the quadriceps muscle (range for all subjects 32-100% predicted). Transdiaphragmatic pressure (Pdi) was measured during a maximal unoccluded sniff (Pdi: sniff), a maximal sustained inspiratory effort against a closed airway (Pdi: Pimax), and phrenic nerve stimulation (Pdi: twitch). Mild to moderate diaphragmatic weakness was present in all six patients in proportion to the degree of leg weakness (Pdi: sniff 30-64% predicted; r = 0.6; Pdi:Pimax 6-69% predicted, r = 0.8); this was associated with very low or absent Pdi:twitch during phrenic nerve stimulation. Four patients had weakness of the expiratory muscles. Improvement in muscle strength was documented in two patients after tumour chemotherapy and specific treatment with 3,4-diaminopyridine and prednisolone; one patient was still alive five years from first diagnosis. It is concluded that the respiratory muscles may be implicated in this condition more often than has previously been recognised. As the lack of mobility may cause respiratory symptoms to be minimised, the presence of respiratory muscle weakness may remain undiagnosed unless formal measurement of respiratory muscle function is made.

Single-shell carbon nanotubes of 1-nm diameter

Abstract: CARBON nanotubes1 are expected to have a wide variety of interesting properties. Capillarity in open tubes has already been demonstrated2–5, while predictions regarding their electronic structure6–8 and mechanical strength9 remain to be tested. To examine the properties of these structures, one needs tubes with well defined morphologies, length, thickness and a number of concentric shells; but the normal carbon-arc synthesis10,11 yields a range of tube types. In particular, most calculations have been concerned with single-shell tubes, whereas the carbon-arc synthesis produces almost entirely multi-shell tubes. Here we report the synthesis of abundant single-shell tubes with diameters of about one nanometre. Whereas the multi-shell nanotubes are formed on the carbon cathode, these single-shell tubes grow in the gas phase. Electron diffraction from a single tube allows us to confirm the helical arrangement of carbon hexagons deduced previously for multi-shell tubes1.

Chemistry and properties of nanocrystals of different shapes.

Abstract: The interest in nanoscale materials stems from the fact that new properties are acquired at this length scale and, equally important, that these properties * To whom correspondence should be addressed. Phone, 404-8940292; fax, 404-894-0294; e-mail, mostafa.el-sayed@ chemistry.gatech.edu. † Case Western Reserve UniversitysMillis 2258. ‡ Phone, 216-368-5918; fax, 216-368-3006; e-mail, burda@case.edu. § Georgia Institute of Technology. 1025 Chem. Rev. 2005, 105, 1025−1102

Carbon Nanotubes: Present and Future Commercial Applications

Abstract: Worldwide commercial interest in carbon nanotubes (CNTs) is reflected in a production capacity that presently exceeds several thousand tons per year. Currently, bulk CNT powders are incorporated in diverse commercial products ranging from rechargeable batteries, automotive parts, and sporting goods to boat hulls and water filters. Advances in CNT synthesis, purification, and chemical modification are enabling integration of CNTs in thin-film electronics and large-area coatings. Although not yet providing compelling mechanical strength or electrical or thermal conductivities for many applications, CNT yarns and sheets already have promising performance for applications including supercapacitors, actuators, and lightweight electromagnetic shields.

Nanoparticle therapeutics: an emerging treatment modality for cancer

Abstract: Nanoparticles — particles in the size range 1–100 nm — are emerging as a class of therapeutics for cancer. Early clinical results suggest that nanoparticle therapeutics can show enhanced efficacy, while simultaneously reducing side effects, owing to properties such as more targeted localization in tumours and active cellular uptake. Here, we highlight the features of nanoparticle therapeutics that distinguish them from previous anticancer therapies, and describe how these features provide the potential for therapeutic effects that are not achievable with other modalities. While large numbers of preclinical studies have been published, the emphasis here is placed on preclinical and clinical studies that are likely to affect clinical investigations and their implications for advancing the treatment of patients with cancer.

Chemistry of Carbon Nanotubes

Abstract: Department of Materials Science, University of Patras, 26504 Rio Patras, Greece, Theoretical and Physical Chemistry Institute, National Hellenic Research Foundation, 48 Vass. Constantinou Avenue, 116 35 Athens, Greece, Institut de Biologie Moleculaire et Cellulaire, UPR9021 CNRS, Immunologie et Chimie Therapeutiques, 67084 Strasbourg, France, and Dipartimento di Scienze Farmaceutiche, Universita di Trieste, Piazzale Europa 1, 34127 Trieste, Italy